Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869362 · ClinicalTrials.gov registry record · NA
Effect of Inpatient Diabetes Management on Outpatient Glycemic Control
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00869362: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00869362 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869362, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The hypothesis of this study is that using hospital admission to identify patients with poorly controlled diabetes (hemoglobin A1c levels \>8%), and intervening during the hospitalization with targeted inpatient diabetes management will improve glycemic control at 3 and 12 months, with inpatient glycemic control, quality of life, and diabetes self-efficacy serving as secondary endpoints.
Interventions
- OTHER Diabetes management team
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869362
The ClinicalTrials.gov registry entry for NCT00869362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diabetes management team is the first listed.
NCT00869362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869362 about?
NCT00869362 is a clinical study titled "Effect of Inpatient Diabetes Management on Outpatient Glycemic Control". The hypothesis of this study is that using hospital admission to identify patients with poorly controlled diabetes (hemoglobin A1c levels \>8%), and intervening during the hospitalization with targeted inpatient diabetes management will improve glycemic control at 3 and 12 months, with inpatient gly...
What is the current status of trial NCT00869362?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2009-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00869362?
The interventions under investigation include: Diabetes management team (OTHER).
Who is sponsoring clinical trial NCT00869362?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.